Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Azitra, Inc. (AZTR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Azitra, Inc. (AZTR), most recent 12 months reported: revenue $0, net loss $12.27M, free cash flow -$11.17M. Latest balance sheet on file: liquid cash $6.73M. From SEC filings. Others in Pharmaceutical Preparations: ARTELO BIOSCIENCES, INC. · ATOSSA THERAPEUTICS, INC. · ARRIVENT BIOPHARMA, INC. · Atea Pharmaceuticals, Inc. · BridgeBio Oncology Therapeutics, Inc. · Bicara Therapeutics Inc. · BRIACELL THERAPEUTICS CORP. · Biohaven Ltd.

Stock screener

Watchlist